Total recalls 11 since 2018
Last 12 months 0 reported
Class I 1 9% of total
Ongoing 0 latest 17 Jan 2024
Recalls per month, last 24 months click a bar for that month Severity split
1 9%3 27%7 64%
Why invagen pharmaceuticals is recalled
All invagen pharmaceuticals recalls, newest first 11 total Reported Class Recall Company Reason Where 17 Jan 2024 Drug CLASS I Vigabatrin for Oral Solution, USP 500 mg per packet, 50 packets recalled Vigabatrin InvaGen Pharmaceuticals Packaging Defects Nationwide 27 May 2020 Drug CLASS III Gabapentin Tablets USP, 600 mg recalled by InvaGen Pharmaceuticals Gabapentin InvaGen Pharmaceuticals Potency & Assay Nationwide 10 Jul 2019 Drug CLASS III Testosterone Topical Solution 30mg of testosterone per pump recalled Testosterone InvaGen Pharmaceuticals Other Nationwide 24 Apr 2019 Drug CLASS II Testosterone Cypionate Injection, USP, 200 mg/mL recalled Testosterone Cypionate InvaGen Pharmaceuticals Particulate Matter Nationwide 24 Apr 2019 Drug CLASS II Testosterone Cypionate Injection, USP, 2000 mg/ (200 mg/mL) recalled Testosterone Cypionate InvaGen Pharmaceuticals Particulate Matter Nationwide 24 Apr 2019 Drug CLASS II Testosterone Cypionate Injection, USP, 1000 mg/ (100 mg/mL) recalled Testosterone Cypionate InvaGen Pharmaceuticals Particulate Matter Nationwide 17 Oct 2018 Drug CLASS III Amlodipine Besylate recalled by InvaGen Pharmaceuticals Amlodipine Besylate InvaGen Pharmaceuticals Potency & Assay Nationwide 26 Sep 2018 Drug CLASS III Bupropion Hydrochloride ER Tablets, USP 150 mg recalled Bupropion Hydrochloride InvaGen Pharmaceuticals Potency & Assay Nationwide 18 Apr 2018 Drug CLASS III Decitabine for Injection, 50mg per vial recalled InvaGen Pharmaceuticals Potency & Assay Nationwide 11 Apr 2018 Drug CLASS III buPROPion HCl Extended-Release Tablets, USP (SR), 100 mg recalled Bupropion Hydrochloride (sr) InvaGen Pharmaceuticals Potency & Assay Nationwide
Load more (1 more)
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.